Namasivayam Ambalavanan1, C Michael Cotten2, Grier P Page3, Waldemar A Carlo4, Jeffrey C Murray5, Soumyaroop Bhattacharya6, Thomas J Mariani6, Alain C Cuna7, Ona M Faye-Petersen8, David Kelly8, Rosemary D Higgins9. 1. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL. Electronic address: nambalavanan@peds.uab.edu. 2. Department of Pediatrics, Duke University, Durham, NC. 3. RTI International, Atlanta, GA. 4. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL. 5. Department of Pediatrics, University of Iowa, Iowa City, IA. 6. Division of Neonatology and Program in Pediatric Molecular and Personalized Medicine, University of Rochester, Rochester, NY. 7. Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO. 8. Department of Pathology, University of Alabama at Birmingham, Birmingham, AL. 9. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.
Abstract
OBJECTIVE: To identify single-nucleotide polymorphisms (SNPs) and pathways associated with bronchopulmonary dysplasia (BPD) because O2 requirement at 36 weeks' postmenstrual age risk is strongly influenced by heritable factors. STUDY DESIGN: A genome-wide scan was conducted on 1.2 million genotyped SNPs, and an additional 7 million imputed SNPs, using a DNA repository of extremely low birth weight infants. Genome-wide association and gene set analysis was performed for BPD or death, severe BPD or death, and severe BPD in survivors. Specific targets were validated via the use of gene expression in BPD lung tissue and in mouse models. RESULTS: Of 751 infants analyzed, 428 developed BPD or died. No SNPs achieved genome-wide significance (P < 10(-8)), although multiple SNPs in adenosine deaminase, CD44, and other genes were just below P < 10(-6). Of approximately 8000 pathways, 75 were significant at false discovery rate (FDR) <0.1 and P < .001 for BPD/death, 95 for severe BPD/death, and 90 for severe BPD in survivors. The pathway with lowest FDR was miR-219 targets (P = 1.41E-08, FDR 9.5E-05) for BPD/death and phosphorous oxygen lyase activity (includes adenylate and guanylate cyclases) for both severe BPD/death (P = 5.68E-08, FDR 0.00019) and severe BPD in survivors (P = 3.91E-08, FDR 0.00013). Gene expression analysis confirmed significantly increased miR-219 and CD44 in BPD. CONCLUSIONS: Pathway analyses confirmed involvement of known pathways of lung development and repair (CD44, phosphorus oxygen lyase activity) and indicated novel molecules and pathways (adenosine deaminase, targets of miR-219) involved in genetic predisposition to BPD.
OBJECTIVE: To identify single-nucleotide polymorphisms (SNPs) and pathways associated with bronchopulmonary dysplasia (BPD) because O2 requirement at 36 weeks' postmenstrual age risk is strongly influenced by heritable factors. STUDY DESIGN: A genome-wide scan was conducted on 1.2 million genotyped SNPs, and an additional 7 million imputed SNPs, using a DNA repository of extremely low birth weight infants. Genome-wide association and gene set analysis was performed for BPD or death, severe BPD or death, and severe BPD in survivors. Specific targets were validated via the use of gene expression in BPD lung tissue and in mouse models. RESULTS: Of 751 infants analyzed, 428 developed BPD or died. No SNPs achieved genome-wide significance (P < 10(-8)), although multiple SNPs in adenosine deaminase, CD44, and other genes were just below P < 10(-6). Of approximately 8000 pathways, 75 were significant at false discovery rate (FDR) <0.1 and P < .001 for BPD/death, 95 for severe BPD/death, and 90 for severe BPD in survivors. The pathway with lowest FDR was miR-219 targets (P = 1.41E-08, FDR 9.5E-05) for BPD/death and phosphorous oxygen lyase activity (includes adenylate and guanylate cyclases) for both severe BPD/death (P = 5.68E-08, FDR 0.00019) and severe BPD in survivors (P = 3.91E-08, FDR 0.00013). Gene expression analysis confirmed significantly increased miR-219 and CD44 in BPD. CONCLUSIONS: Pathway analyses confirmed involvement of known pathways of lung development and repair (CD44, phosphorus oxygen lyase activity) and indicated novel molecules and pathways (adenosine deaminase, targets of miR-219) involved in genetic predisposition to BPD.
Authors: Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber Journal: Am J Respir Crit Care Med Date: 2012-06-21 Impact factor: 21.405
Authors: Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt Journal: Am J Respir Crit Care Med Date: 2011-08-11 Impact factor: 21.405
Authors: Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich Journal: Pediatrics Date: 2013-07-29 Impact factor: 7.124
Authors: Stephanie M Gogarten; Tushar Bhangale; Matthew P Conomos; Cecelia A Laurie; Caitlin P McHugh; Ian Painter; Xiuwen Zheng; David R Crosslin; David Levine; Thomas Lumley; Sarah C Nelson; Kenneth Rice; Jess Shen; Rohit Swarnkar; Bruce S Weir; Cathy C Laurie Journal: Bioinformatics Date: 2012-10-10 Impact factor: 6.937
Authors: Jun Li; Azhar Masood; Man Yi; Mandy Lau; Rosetta Belcastro; Julijana Ivanovska; Robert P Jankov; A Keith Tanswell Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-03-01 Impact factor: 5.464
Authors: Yuejuan Li; Dianhua Jiang; Jiurong Liang; Eric B Meltzer; Alice Gray; Riu Miura; Lise Wogensen; Yu Yamaguchi; Paul W Noble Journal: J Exp Med Date: 2011-06-27 Impact factor: 14.307
Authors: Dana B Hancock; Joshua L Levy; Nathan C Gaddis; Laura J Bierut; Nancy L Saccone; Grier P Page; Eric O Johnson Journal: PLoS One Date: 2012-11-30 Impact factor: 3.240
Authors: John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray Journal: J Perinatol Date: 2018-12-05 Impact factor: 2.521
Authors: Laura R Ment; Ulrika Ådén; Charles R Bauer; Henrietta S Bada; Waldemar A Carlo; Jeffrey R Kaiser; Aiping Lin; Charles Michael Cotten; Jeffrey Murray; Grier Page; Mikko Hallman; Richard P Lifton; Heping Zhang Journal: Semin Perinatol Date: 2015-10-26 Impact factor: 3.300